Yuan-Yuan Chen (Yuanyuan Chen, Chen Yuan-Yuan, C Yuanyuan)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Placebo Controlled

Epidermal Growth Factor Receptor

Cross Sectional

Top Venues

Cancer biology & medicine

Journal of cancer research and clinical oncology

BioMed research international

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

This page only lists publications with an associated author ORCID identifier.

Publications

Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuan-Yuan Chen, Ming Chen
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial. Cancer biology & medicine (2024)
Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuan-Yuan Chen, Ming Chen
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial. Cancer biology & medicine 21 (5) (2024)
Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuan-Yuan Chen, Ming Chen
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial. Cancer biology & medicine 21 (5) (2024)
Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuan-Yuan Chen, Ming Chen
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial. Cancer biology & medicine 21 (5) (2024)
Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuan-Yuan Chen, Ming Chen
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial. Cancer biology & medicine 21 (5) (2024)
Ling Zhou, Jia Chen, Chang-Juan Tao, Shuang Huang, Jiang Zhang, Wei Shen, Chao-Nan Zhu, Ming Chen, Zhong-Hua Yu, Yuan-Yuan Chen
Hematological Indexes Can Be Used to Predict the Incidence of Hypothyroidism in Nasopharyngeal Carcinoma Patients after Radiotherapy. BioMed research international 2020 (2020)
Zekai Shu, Baiqiang Dong, Lei Shi, Wei Shen, Qingqing Hang, Jin Wang, Yuan-Yuan Chen
Correction to: Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early‑stage non‑small cell lung cancer. Journal of cancer research and clinical oncology (2020)
Zekai Shu, Baiqiang Dong, Lei Shi, Wei Shen, Qingqing Hang, Jin Wang, Yuan-Yuan Chen
Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer. Journal of cancer research and clinical oncology 146 (5) (2020)
Sun Zong-Wen, Yang Shuang-Yan, Du Feng-Lei, Cheng Xiao-Long, Qinglin Li, Chen Meng-Yuan, Hua Yong-Hong, Jin Ting, Hu Qiao-Ying, Chen Xiao-Zhong, Yuan-Yuan Chen, Ming Chen
Radiotherapy for Adult Medulloblastoma: Evaluation of Helical Tomotherapy, Volumetric Intensity Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy and the Results of Helical Tomotherapy Therapy. BioMed research international 2018 (2018)
H Shuang, J Feng, C Caineng, J Qifeng, J Tin, Yuan-Yuan Chen, C Xiaozhong
The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (2) (2018)